Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05800951 · ClinicalTrials.gov registry record
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
A clinical trial, sponsored by Henry Ford Health System.
- Active
- Registry status
- 124
- Enrollment target
NCT05800951 is a clinical trial that is active but no longer recruiting, run by Henry Ford Health System. The registered enrollment target is 124 participants.
The verdict
NCT05800951 is active but no longer recruiting, sponsored by Henry Ford Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 124 participants
- Enrollment target
Study Summary
The CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated with mechanical circulatory support (MCS) devices in the United States with significant experience in MCS, all of whom have the capability of MCS escalation on-site. Study enrollment is targeted at 120 patients at 20 hospital sites, evaluating clinical outcomes, and focusing on outcomes MCS escalation decision making and ICU level management.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2022-07-22 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05800951
The ClinicalTrials.gov registry entry for NCT05800951 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05800951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05800951 about?
NCT05800951 is a clinical study titled "Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock". The CERAMICS study is designed to more clearly delineate the current care of acute myocardial infarction with cardiogenic shock (AMICS) patients who are treated with mechanical circulatory support (MCS) devices in the United States with significant experience in MCS, all of whom have the capability ...
What is the current status of trial NCT05800951?
This trial is currently active not recruiting. The enrollment target is 124 participants. The study started on 2022-07-22. Estimated completion is 2026-12-31.
Who is sponsoring clinical trial NCT05800951?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.